Uremic cardiomyopathy - An endogenous digitalis intoxication?

Journal of the American Society of Nephrology

Volumn 17, Issue 6, 2006, Pages 1493-1497

  Ritz, Eberhard ^a  

^a Division of Nephrology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) INHIBITOR; ANTIOXIDANT; BUFADIENOLIDE; CARDIOTONIC AGENT; DIGITALIS LIKE FACTOR; MARINOBUFAGENIN; OUABAIN; STEROID; TELOCINOBUFAGENIN; UNCLASSIFIED DRUG;

BLOOD PRESSURE; CALCIUM TRANSPORT; CARDIOMYOPATHY; DOSE RESPONSE; DRUG DESIGN; DRUG TARGETING; EXTRACELLULAR SPACE; HEART DEATH; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INOTROPISM; NONHUMAN; NOTE; PARTIAL NEPHRECTOMY; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; SODIUM EXCRETION; UREMIA;

EID: 33744929615     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006040389     Document Type: Note

References (42)

1. Bright R: Tabular view of the morbid appearence in 100 cases with albuminous urine. Guy's Hosp Rep 1: 380-400, 1846
2. Volhard F, Fahr T: Die Bright'sche Nierenkrankheit. Berlin, Julius Springer Verlag, 1914
3. Mason MF, RHJ, Minot AS, Rainey J, Pilcher C, Harrison TR: Mechanism of exoerimental uremia. Archs IntMed 60: 312, 1937
4. Nivatpumin T, Yipintsoi T, Penpargkul S, Scheuer J: Increased cardiac contractility in acute uremia: Interrelationship with hypertension. Am J Physiol 229: 501-505, 1975
5. Welt LG: A further evaluation of erythrocyte sodium transport in control subjects and patients with uremia. Nephron 6: 406-417, 1969
6. Penpargkul S, Bhan AK, Scheuer J: Studies of subcellular control factors in hearts of uremic rats. J Lab Clin Med 88: 563-570, 1976
7. Fiehn W, Seiler D, Heimberg KW: Transport ATPases of cardiac sarcolemma in experimental uremia. Clin Chim Acta 73: 93-96, 1976
8. Adler D, Fiehn W, Ritz E: Inhibition of Na+, K+-stimulated ATPase in the cochlea of the guinea pig. A potential cause of disturbed inner ear function in terminal renal failure. Acta Otolaryngol 90: 55-60, 1980
9. Klingmuller D, Weiler E, Kramer HJ: Digoxin-like natriuretic activity in the urine of salt loaded healthy subjects. Klin Wochenschr 60: 1249-1253, 1982
10. Lowenstein JM: A method for measuring plasma levels of digitalis glycosides. Circulation 31: 228-233, 1965
11. Kreusser W, Klooker P, Rambausek M, Ritz E: Digitalis treatment in uremic patients. Contrib Nephrol 41: 255-261, 1984
12. Szent-Györgyi A: Chemical Physiology of Contraction. New York, Academic Press, 1953
13. Bricker NS: The control of sodium excretion with normal and reduced nephron populations. The pre-eminence of third factor. Am J Med 43: 313-321, 1967
14. Nutbourne DM, Howse JD, Schrier RW, Talner LB, Ventom MG, Verroust PJ, De Wardener HE: The effect of expanding the blood volume of a dog on the short-circuit current across an isolated frog skin incorporated in the dog's circulation. Clin Sci 38: 629-648, 1970
15. Blaustein MP, Juhaszova M, Golovina VA: The cellular mechanism of action of cardiotonic steroids: A new hypothesis. Clin Exp Hypertens 20: 691-703, 1998
16. Bricker NS: On the pathogenesis of the uremic state. An exposition of the "trade-off hypothesis". N Engl J Med 286: 1093-1099, 1972
17. de Wardener HE, MacGregor GA: The relation of a circulating sodium transport inhibitor (the natriuretic hormone?) to hypertension. Medicine (Baltimore) 62: 310-326, 1983
18. Scheiner-Bobis G, Schoner W: A fresh facet for ouabain action. Nat Med 7: 1288-1289, 2001
19. Hamlyn JM, Lu ZR, Manunta P, Ludens JH, Kimura K, Shah JR, Laredo J, Hamilton JP, Hamilton MJ, Hamilton BP: Observations on the nature, biosynthesis, secretion and significance of endogenous ouabain. Clin Exp Hypertens 20: 523-533, 1998
20. Dmitrieva RI, Lalli E, Doris PA: Regulation of adrenocortical cardiotonic steroid production by dopamine and PKA signaling. Front Biosci 10: 2489-2495, 2005
21. Schoner W: Endogenous cardiac glycosides, a new class of steroid hormones. Eur J Biochem 269: 2440-2448, 2002
22. Gottlieb SS, Rogowski AC, Weinberg M, Krichten CM, Hamilton BP, Hamlyn JM: Elevated concentrations of endogenous ouabain in patients with congestive heart failure. Circulation 86: 420-425, 1992
23. Ferrari P, Ferrandi M, Tripodi G, Torielli L, Padoani G, Minotti E, Melloni P, Blanchi G: PST 2238: A new antihypertensive compound that modulates Na, K-ATPase in genetic hypertension. J Pharmacol Exp Ther 288: 1074-1083, 1999
24. Xie Z, Askari A: Na(+)/K(+)-ATPase as a signal transducer. Eur J Biochem 269: 2434-2439, 2002
25. Abramowitz J, Dai C, Hirschi KK, Dmitrieva RI, Doris PA, Liu L, Allen JC: Ouabain- and marinobufagenin-induced proliferation of human umbilical vein smooth muscle cells and a rat vascular smooth muscle cell line, A7r5. Circulation 108: 3048-3053, 2003
26. Cunha Filho GA, Schwartz CA, Resck IS, Murta MM, Lemos SS, Castro MS, Kyaw C, Pires OR Jr, Leite JR, Bloch C Jr, Schwartz EF: Antimicrobial activity of the bufadienolides marinobufagin and telocinobufagin isolated as major components from skin secretion of the toad Bufo rubescens. Toxicon 45: 777-782, 2005
27. Fedorova OV, Lakatta EG, Bagrov AY: Endogenous Na, K pump ligands are differentially regulated during acute NaCl loading of Dahl rats. Circulation 102: 3009-3014, 2000
28. Fedorova OV, Kolodkin NI, Agalakova NI, Lakatta EG, Bagrov AY: Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats. Hypertension 37: 462-466, 2001
29. Bagrov YY, Manusova NB, Egorova IA, Fedorova OV, Bagrov AY: Endogenous digitalis-like ligands and Na/K-ATPase inhibition in experimental diabetes mellitus. Front Biosci 10: 2257-2262, 2005
30. Vu HV, Ianosi-Irimie MR, Pridjian CA, Whitbred JM, Durst JM, Bagrov AY, Fedorova OV, Pridjian G, Puschett JB: Involvement of marinobufagenin in a rat model of human pre-eclampsia. Am J Nephrol 25: 520-528, 2005
31. Komiyama Y, Dong XH, Nishimura N, Masaki H, Yoshika M, Masuda M, Takahashi H: A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure. Clin Biochem 38: 36-45, 2005
32. Fridman AI, Matveev SA, Agalakova NI, Fedorova OV, Lakatta EG, Bagrov AY: Marinobufagenin, an endogenous ligand of alpha-1 sodium pump, is a marker of congestive heart failure severity. J Hypertens 20: 1189-1194, 2002
33. Bagrov AY, Fedorova OV, Dmitrieva RI, Howald WN, Hunter AP, Kuznetsova EA, Shpen VM: Characterization of a urinary bufodienolide Na+, K+-ATPase inhibitor in patients after acute myocardial infarction. Hypertension 31: 1097-1103, 1998
34. Kennedy DJ, Vetteth S, Periyasamy SM, Kanj M, Fedorova L, Khouri S, Kahaleh MB, Xie Z, Malhotra D, Kolodkin NI, Lakatta EG, Fedorova OV, Bagrov AY, Shapiro JI: Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension 47: 488-495, 2006
35. Kennedy D, Omran E, Periyasamy SM, Nadoor J, Priyadarshi A, Willey JC, Malhotra D, Xie Z, Shapiro JI: Effect of chronic renal failure on cardiac contractile function, calcium cycling, and gene expression of proteins important for calcium homeostasis in the rat. J Am Soc Nephrol 14: 90-97, 2003
36. Matthews C, Heimberg KW, Ritz E, Agostini B, Fritzsche J, Hasselbach W: Effect of 1,25-dihydroxycholecalciferol on impaired calcium transport by the sarcoplasmic reticulum in experimental uremia. Kidney Int 11: 227-235, 1977
37. Mall G, Rambausek M, Neumeister A, Kollmar S, Vetterlein F, Ritz E: Myocardial interstitial fibrosis in experimental uremia-Implications for cardiac compliance. Kidney Int 33: 804-811, 1988
38. Yamamoto M, Yang G, Hong C, Liu J, Holle E, Yu X, Wagner T, Vatner SF, Sadoshima J: Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J Clin Invest 112: 1395-1406, 2003
39. Xie Z, Kometiani P, Liu J, Li J, Shapiro JI, Askari A: Intracellular reactive oxygen species mediate the linkage of Na+/K+-ATPase to hypertrophy and its marker genes in cardiac myocytes. J Biol Chem 274: 19323-19328, 1999
40. Rambausek M, Ritz E, Mall G, Mehls O, Katus H: Myocardial hypertrophy in rats with renal insufficiency. Kidney Int 28: 775-782, 1985
41. Himmelfarb J, Hakim RM: Oxidative stress in uremia. Curr Opin Nephrol Hypertens 12: 593-598, 2003
42. Fedorova OV, Agalakova NI, Talan MI, Lakatta EG, Bagrov AY: Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats. J Hypertens 23: 1515-1523, 2005